189 related articles for article (PubMed ID: 24632247)
1. Probing for chemotherapy-induced peripheral neuropathy in live dorsal root ganglion neurons with atomic force microscopy.
Au NP; Fang Y; Xi N; Lai KW; Ma CH
Nanomedicine; 2014 Aug; 10(6):1323-33. PubMed ID: 24632247
[TBL] [Abstract][Full Text] [Related]
2. Editor's Highlight: Multiparametric Image Analysis of Rat Dorsal Root Ganglion Cultures to Evaluate Peripheral Neuropathy-Inducing Chemotherapeutics.
Guo L; Hamre J; Eldridge S; Behrsing HP; Cutuli FM; Mussio J; Davis M
Toxicol Sci; 2017 Mar; 156(1):275-288. PubMed ID: 28115644
[TBL] [Abstract][Full Text] [Related]
3. Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.
Zhang H; Boyette-Davis JA; Kosturakis AK; Li Y; Yoon SY; Walters ET; Dougherty PM
J Pain; 2013 Oct; 14(10):1031-44. PubMed ID: 23726937
[TBL] [Abstract][Full Text] [Related]
4. A novel endpoint for the assessment of chemotherapy-induced peripheral neuropathy in rodents: biomechanical properties of peripheral nerve.
Liu CN; Berryman E; Zakur D; Shoieb AM; Pardo ID; Boucher M; Somps CJ; Bagi CM; Cook JC
J Appl Toxicol; 2018 Feb; 38(2):193-200. PubMed ID: 28815646
[TBL] [Abstract][Full Text] [Related]
5. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
Chine VB; Au NPB; Kumar G; Ma CHE
Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
Tonello R; Lee SH; Berta T
J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
[TBL] [Abstract][Full Text] [Related]
7. Integrins protect sensory neurons in models of paclitaxel-induced peripheral sensory neuropathy.
Shin GJ; Pero ME; Hammond LA; Burgos A; Kumar A; Galindo SE; Lucas T; Bartolini F; Grueber WB
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876743
[TBL] [Abstract][Full Text] [Related]
8. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy.
Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM
J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth.
Van Helleputte L; Kater M; Cook DP; Eykens C; Rossaert E; Haeck W; Jaspers T; Geens N; Vanden Berghe P; Gysemans C; Mathieu C; Robberecht W; Van Damme P; Cavaletti G; Jarpe M; Van Den Bosch L
Neurobiol Dis; 2018 Mar; 111():59-69. PubMed ID: 29197621
[TBL] [Abstract][Full Text] [Related]
10. Identification of fluocinolone acetonide to prevent paclitaxel-induced peripheral neuropathy.
Cetinkaya-Fisgin A; Joo MG; Ping X; Thakor NV; Ozturk C; Hoke A; Yang IH
J Peripher Nerv Syst; 2016 Sep; 21(3):128-33. PubMed ID: 27117347
[TBL] [Abstract][Full Text] [Related]
11. Comparative Analysis of Chemotherapy-Induced Peripheral Neuropathy in Bioengineered Sensory Nerve Tissue Distinguishes Mechanistic Differences in Early-Stage Vincristine-, Cisplatin-, and Paclitaxel-Induced Nerve Damage.
Pollard KJ; Bolon B; Moore MJ
Toxicol Sci; 2021 Feb; 180(1):76-88. PubMed ID: 33410881
[TBL] [Abstract][Full Text] [Related]
12. High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy.
Gu H; Wang C; Li J; Yang Y; Sun W; Jiang C; Li Y; Ni M; Liu WT; Cheng Z; Hu L
Int J Cancer; 2020 May; 146(10):2810-2821. PubMed ID: 31465111
[TBL] [Abstract][Full Text] [Related]
13. Orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy.
Singhmar P; Huo X; Li Y; Dougherty PM; Mei F; Cheng X; Heijnen CJ; Kavelaars A
Pain; 2018 May; 159(5):884-893. PubMed ID: 29369966
[TBL] [Abstract][Full Text] [Related]
14. Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat.
Topp KS; Tanner KD; Levine JD
J Comp Neurol; 2000 Sep; 424(4):563-76. PubMed ID: 10931481
[TBL] [Abstract][Full Text] [Related]
15. Sodium channel Nav1.6 in sensory neurons contributes to vincristine-induced allodynia.
Chen L; Huang J; Benson C; Lankford KL; Zhao P; Carrara J; Tan AM; Kocsis JD; Waxman SG; Dib-Hajj SD
Brain; 2020 Aug; 143(8):2421-2436. PubMed ID: 32830219
[TBL] [Abstract][Full Text] [Related]
16. Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats.
Nishida T; Tsubota M; Kawaishi Y; Yamanishi H; Kamitani N; Sekiguchi F; Ishikura H; Liu K; Nishibori M; Kawabata A
Toxicology; 2016 Jul; 365():48-58. PubMed ID: 27474498
[TBL] [Abstract][Full Text] [Related]
17. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.
LaPointe NE; Morfini G; Brady ST; Feinstein SC; Wilson L; Jordan MA
Neurotoxicology; 2013 Jul; 37():231-9. PubMed ID: 23711742
[TBL] [Abstract][Full Text] [Related]
18. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.
Krukowski K; Nijboer CH; Huo X; Kavelaars A; Heijnen CJ
Pain; 2015 Nov; 156(11):2184-2192. PubMed ID: 26473292
[TBL] [Abstract][Full Text] [Related]
19. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
Kume M; Ahmad A; DeFea KA; Vagner J; Dussor G; Boitano S; Price TJ
J Pain; 2023 Nov; 24(11):1980-1993. PubMed ID: 37315729
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy.
Hu Y; Girdenyté M; Roest L; Liukkonen I; Siskou M; Bällgren F; Hammarlund-Udenaes M; Loryan I
Fluids Barriers CNS; 2024 Feb; 21(1):13. PubMed ID: 38331886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
